tirzepatide mayo clinic New study links combination of hormone therapy and to greater weight loss after menopause Mayo Clinic Minute: Weaning off
Description
The clients I work with who are on Mounjaro or tirzepatide have had mixed experiences, says Rachel Goldberg, LMFT, PMH-C , a Los Angeles-based therapist who specializes in eating disorders
F., de la Fuente, J
Dehydration can sometimes be mistaken for hunger or even nausea, so keeping your fluid intake up is crucial
Tirzepatide (Mounjaro, Zepbound) is a once-weekly injectable medication that combines GIP and GLP-1 receptor agonist activity for type 2 diabetes and chronic weight management
Most people naturally reduce their daily calorie intake by 500 to 1,000 calories without conscious restriction or willpower battles
At the doses delivered through the compound formulation (5 to 30 mg per week), accumulation to toxic levels is extremely unlikely
